Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
29 Results Found
Telemedicine Prescribing of Controlled Substances
The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Jan. 15 released a proposed rule on special registration for prescribing of controlled substances and a final rule on telemedicine prescribing of buprenorphine.
DEA and HHS Extend Waivers for Prescribing Controlled Substances Through Telemedicine
The Department of Health and Human Services (HHS) and Drug Enforcement Administration (DEA) Dec. 30 released a temporary rule extending for the fourth time waiver flexibilities for prescribing controlled substances via telemedicine.
Hospital connects opiate-dependent individuals with treatment, resources
Charlotte Hungerford Hospital’s Connecticut Mental Health Center has a certified opiate addiction counselor that helps individuals who are dependent on opiates connect with resources throughout the region.
Englewood Health's Strategies to Combat Rising Opioid Use in Post-Pandemic America
In this conversation, Vinnidhy Dave, D.O., hospice specialist and director of palliative medicine at Englewood Health Physician Network, and Lauren Savage, director of population health at Englewood Hospital, discuss what Englewood Health is doing to prevent opioid use in its communities.
It Takes a Village: A New Approach to Opioid Abuse Helps Mothers and Babies
In this conversation, Chris DeRienzo, M.D., SVP and chief physician executive at the AHA, speaks with three WISH Center experts about how its approach is helping to protect the health of new mothers and their babies.
Thinking Outside the Box to Reduce Behavioral Health Stigma and Disparities in Health Outcomes
For underserved populations, stigma and lack of access to behavioral health services can present huge barriers to treatment.
Study examines increase in states banning prior authorization in private health plans for OUD medications
A Health Affairs study published Nov. 3 examined an increase in states banning prior authorizations in private insurance plans for opioid use disorder medications.
HHS awards $1.5 billion in opioid response grants to states, tribal communities
HHS awards $1.5 billion in opioid response grants to states, tribal communities
FDA issues guidance to expand non-opioid treatments for chronic pain
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.
Study finds less than 40% of Medicare beneficiaries with OUD receive standard care
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with quality measures.